Arabic Arabic English English French French German German
dark

Athenex Announces Agreement with ImmunityBio Regarding Dunkirk Manufacturing Facility

Athenex, Inc. announced that it has entered into a definitive agreement for ImmunityBio, Inc. to assume its leasehold interest in a manufacturing facility in Dunkirk, New York, and certain related assets for approximately $38 million, subject to adjustment at closing. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

40% of eligible population have had boosters; 28 community cases; 2 deaths; 31 people in hospital; two in ICU

Next Post

The unexpected benefits of fat in type 2 diabetes

Related Posts
Total
0
Share